Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | 22.45%6.6M | 367.08%9.28M | 35.43%5.39M | 122.79%1.99M | 135.17%3.98M | -662.49%-8.72M | -3,458.35%-11.31M | -53.35%1.55M | 182.03%336.87K | 519.47%3.32M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 8.70%-772.97K | -70.85%-1.45M | -353.28%-846.65K | -1,069.29%-846.65K | -2,162.10%-186.78K | -121.77%-72.41K | 62.51%-8.26K | 67.98%-32.65K | 68.70%-22.03K | 37.12%-101.95K |
| Impairment and provisions: | ---- | ---- | ---- | ---- | ---- | --1.84M | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | --1.84M | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.83K | ---5.17K |
| -Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6.83K | ---5.17K |
| Asset sale loss (gain): | ---7.89K | -15,207.01%-4.83M | ---- | ---31.56K | ---31.56K | ---- | ---- | -10.41%-8K | ---8K | -90,675.00%-7.25K |
| -Loss (gain) on sale of property, machinery and equipment | ---7.89K | ---- | ---- | ---31.56K | ---31.56K | ---- | ---- | -10.41%-8K | ---8K | -90,675.00%-7.25K |
| -Loss (gain) from selling other assets | ---- | ---4.83M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | -22.55%933.49K | -10.64%2.32M | -6.91%1.21M | 1.41%2.6M | 3.59%1.29M | 6.05%2.56M | 3.96%1.25M | -10.06%2.42M | -10.36%1.2M | 7.02%2.69M |
| Financial expense | -32.91%167.7K | -32.97%437.5K | -26.14%249.95K | 54.46%652.67K | 96.56%338.41K | 19.33%422.55K | -10.63%172.17K | -34.93%354.09K | -38.17%192.66K | -9.51%544.13K |
| Exchange Loss (gain) | ---- | -210.33%-151.66K | ---- | 515.66%137.46K | ---- | 75.90%-33.07K | ---- | -52.73%-137.21K | ---- | -176.97%-89.84K |
| Unrealized exchange loss (gain) | 133.86%85.15K | ---- | -433.22%-251.51K | ---- | 79.21%-47.17K | ---- | -53.41%-226.88K | ---- | 71.36%-147.89K | ---- |
| Special items | ---- | ---- | 73.97%-245.61K | --221.48K | -130.64%-943.44K | ---- | --3.08M | ---11.7K | ---- | ---- |
| Operating profit before the change of operating capital | 27.34%7M | 18.88%5.61M | 24.92%5.5M | 218.27%4.72M | 162.49%4.4M | -196.59%-3.99M | -555.53%-7.05M | -34.93%4.13M | 136.07%1.55M | 76.18%6.35M |
| Change of operating capital | ||||||||||
| Developing property (increase)decrease | 95.22%-4.11M | ---90.25M | ---85.87M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Accounts receivable (increase)decrease | -56.30%2.93M | -18.57%2.61M | 297.53%6.7M | 137.69%3.2M | 130.91%1.68M | -956.49%-8.49M | -1,083.97%-5.45M | 68.20%991.1K | -80.38%553.77K | 307.23%589.23K |
| Accounts payable increase (decrease) | 129.36%8.03M | -319.01%-17.73M | -5,123.56%-27.36M | -52.45%8.1M | -127.19%-523.74K | 2,169.39%17.02M | 119.70%1.93M | -95.07%750.13K | 7.15%-9.78M | 185.62%15.23M |
| Special items for working capital changes | -132.95%-7.35M | 79.33%29.71M | 7,020.09%22.32M | 318.76%16.57M | 85.28%-322.54K | -87.07%-7.57M | -122.15%-2.19M | 50.06%-4.05M | 0.06%9.9M | 35.23%-8.11M |
| Cash from business operations | 108.26%6.5M | -315.00%-70.05M | -1,601.73%-78.71M | 1,175.28%32.58M | 141.07%5.24M | -265.98%-3.03M | -674.98%-12.76M | -87.02%1.83M | -21.78%2.22M | 464.01%14.06M |
| Other taxs | -323.07%-405.17K | 21.90%-145.12K | 4.22%-95.77K | 63.73%-185.8K | 61.69%-99.99K | 25.72%-512.22K | 62.53%-260.98K | -24.26%-689.59K | -50.30%-696.58K | 16.37%-554.97K |
| Net cash from operations | 107.74%6.1M | -316.68%-70.2M | -1,632.80%-78.81M | 1,014.55%32.4M | 139.48%5.14M | -411.81%-3.54M | -955.11%-13.02M | -91.59%1.14M | -35.86%1.52M | 398.39%13.51M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -64.46%224.64K | 51.11%1.19M | 2,086.15%632.06K | 2,315.23%785.99K | 250.15%28.91K | -0.32%32.54K | -62.51%8.26K | -73.89%32.65K | -64.33%22.03K | -53.71%125.07K |
| Loan receivable (increase) decrease | ---- | ---- | ---- | --182 | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | -590.59%-7.05M | -226.14%-13.91M | 226.80%1.44M | -531.34%-4.26M | ---1.13M | --988.77K | ---- | ---- | ---- | ---- |
| Sale of fixed assets | --7.89K | ---- | ---- | --31.56K | --31.56K | ---- | ---- | 10.41%8K | --8K | 126.44%7.25K |
| Purchase of fixed assets | ---17.4K | ---- | ---- | 78.87%-168.41K | 56.53%-168.41K | -36.89%-797.04K | -330.74%-387.39K | -363.97%-582.25K | ---89.94K | 94.63%-125.49K |
| Recovery of cash from investments | ---- | --12.69M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---18.56M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 199.92%10.02M | ---- | ---10.02M |
| Net cash from investment operations | -1,327.35%-25.39M | 99.12%-31.77K | 266.71%2.07M | -1,712.17%-3.62M | -227.29%-1.24M | -97.63%224.27K | -532.83%-379.13K | 194.58%9.48M | -156.13%-59.91K | -202.98%-10.02M |
| Net cash before financing | 74.86%-19.29M | -344.01%-70.23M | -2,067.38%-76.74M | 967.40%28.78M | 129.11%3.9M | -131.27%-3.32M | -1,016.04%-13.4M | 204.10%10.61M | -37.77%1.46M | 144.55%3.49M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | --82.69M | --64.94M | ---- | ---- | ---- | ---- | ---- | ---- | 6.61%5M |
| Refund | -1.73%-1.23M | -2.05%-2.45M | -0.82%-1.21M | -1.94%-2.4M | -2.79%-1.2M | 68.68%-2.36M | 82.80%-1.17M | -444.30%-7.52M | -913.60%-6.79M | -42.26%-1.38M |
| Interest paid - financing | -74.58%-1.35M | -267.92%-2.41M | -125.86%-772.53K | -62.12%-656.25K | ---342.03K | -11.75%-404.8K | ---- | 35.27%-362.25K | ---- | 4.65%-559.63K |
| Other items of the financing business | ---- | --550 | --15.51M | ---- | ---- | ---- | 16.62%-167.13K | ---- | 37.42%-200.43K | ---- |
| Net cash from financing operations | -103.43%-2.69M | 2,470.82%77.6M | 4,873.33%78.38M | -10.01%-3.27M | -14.99%-1.64M | 63.14%-2.98M | 79.84%-1.43M | -397.31%-8.07M | -509.11%-7.08M | -2.55%2.71M |
| Effect of rate | -133.86%-85.15K | 210.33%151.66K | 433.22%251.51K | -515.66%-137.46K | -79.21%47.17K | -75.90%33.07K | 53.41%226.88K | 19.53%137.21K | -71.36%147.89K | 198.35%114.79K |
| Net Cash | -1,437.79%-21.98M | -71.10%7.37M | -27.25%1.64M | 505.32%25.51M | 115.23%2.26M | -347.74%-6.29M | -163.91%-14.83M | -59.06%2.54M | -572.96%-5.62M | 222.91%6.2M |
| Begining period cash | 13.61%62.79M | 84.87%55.26M | 84.87%55.26M | -17.32%29.89M | -17.32%29.89M | 8.00%36.15M | 8.00%36.15M | 23.27%33.48M | 23.27%33.48M | -15.98%27.16M |
| Cash at the end | -28.76%40.72M | 13.61%62.79M | 77.52%57.16M | 84.87%55.26M | 49.41%32.2M | -17.32%29.89M | -23.05%21.55M | 8.00%36.15M | -2.97%28M | 23.27%33.48M |
| Cash balance analysis | ||||||||||
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang | -- | Deloitte & Touche LLP, Deloitte Guan Huang Chen Fang |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.